InvestorsHub Logo
Followers 2
Posts 697
Boards Moderated 0
Alias Born 04/08/2008

Re: tob999 post# 3957

Wednesday, 09/15/2010 11:07:52 AM

Wednesday, September 15, 2010 11:07:52 AM

Post# of 20669
Default understanding: TESTS! yes, DNA marker tests


If InoLife captures JUST 5% of the existing market share for TESTING METABOLIC RATE BECAUSE OF THE NEW FDA BLACK BOX WARNING and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:

$5.56

That's EBITDA, etc. But also without a multiple.

Lop off 40% for margin of error, and it's $3.34

Imagine if 50% market share, or 80%


legend:

5%Mkt share * 9M new Plavix users 3 months = 450,000

5%Mkt share * 48M Plavix users = 2.4M

128 OS

$250 cost